Know the Latest Buprenorphine Option for Opioid Use Disorder
January 1
Another ER buprenorphine injection (Brixadi) for moderate to severe opioid use disorder is now available.
It’s still the partial agonist we know...but has differences from other buprenorphine products (Suboxone, Sublocade, etc).
Brixadi ($1,600/month) costs more than generic options, such as sublingual buprenorphine/naloxone tabs averaging $390/month, but Sublocade ($1,900/month) is similar in price.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote